These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1335247)
21. Glucocorticoid up-regulation of high-affinity interleukin 6 receptors on human epithelial cells. Snyers L; De Wit L; Content J Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2838-42. PubMed ID: 2157217 [TBL] [Abstract][Full Text] [Related]
22. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. Honda M; Yamamoto S; Cheng M; Yasukawa K; Suzuki H; Saito T; Osugi Y; Tokunaga T; Kishimoto T J Immunol; 1992 Apr; 148(7):2175-80. PubMed ID: 1545125 [TBL] [Abstract][Full Text] [Related]
23. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression. Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795 [TBL] [Abstract][Full Text] [Related]
24. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Hashizume M; Hayakawa N; Mihara M Rheumatology (Oxford); 2008 Nov; 47(11):1635-40. PubMed ID: 18786965 [TBL] [Abstract][Full Text] [Related]
25. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. Müllberg J; Durie FH; Otten-Evans C; Alderson MR; Rose-John S; Cosman D; Black RA; Mohler KM J Immunol; 1995 Dec; 155(11):5198-205. PubMed ID: 7594530 [TBL] [Abstract][Full Text] [Related]
26. The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity. Zucali JR; Morse C; Dinarello CA Exp Hematol; 1990 Sep; 18(8):888-92. PubMed ID: 2167234 [TBL] [Abstract][Full Text] [Related]
27. Shedding of the soluble IL-6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells. Jones SA; Horiuchi S; Novick D; Yamamoto N; Fuller GM Eur J Immunol; 1998 Nov; 28(11):3514-22. PubMed ID: 9842894 [TBL] [Abstract][Full Text] [Related]
28. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. Müllberg J; Oberthür W; Lottspeich F; Mehl E; Dittrich E; Graeve L; Heinrich PC; Rose-John S J Immunol; 1994 May; 152(10):4958-68. PubMed ID: 8176214 [TBL] [Abstract][Full Text] [Related]
29. Ligand-induced phosphorylation of the murine interleukin 3 receptor signals its cleavage. Mui AL; Kay RJ; Humphries RK; Krystal G Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10812-6. PubMed ID: 1332057 [TBL] [Abstract][Full Text] [Related]
30. Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family. Mihara M; Kasutani K; Okazaki M; Nakamura A; Kawai S; Sugimoto M; Matsumoto Y; Ohsugi Y Int Immunopharmacol; 2005 Nov; 5(12):1731-40. PubMed ID: 16102523 [TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. Gabay C; Silacci P; Genin B; Mentha G; Le Coultre C; Guerne PA Eur J Immunol; 1995 Aug; 25(8):2378-83. PubMed ID: 7545121 [TBL] [Abstract][Full Text] [Related]
32. Soluble interleukin 6 (IL-6) receptor influences the expression of the protooncogene junB and the production of fibrinogen in the HepG2 human hepatoma cell line and primary rat hepatocytes. Igaz P; Tóth S; Rose-John S; Madurka I; Fejér G; Szalai C; Falus A Cytokine; 1998 Aug; 10(8):620-6. PubMed ID: 9722935 [TBL] [Abstract][Full Text] [Related]
33. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases. Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322 [TBL] [Abstract][Full Text] [Related]
34. Differential effects of phorbol esters on proliferation and calcyclin expression in human endometrial carcinoma cells. Gong Y; Alkhalaf B; Murphy LJ; Murphy LC Cell Growth Differ; 1992 Nov; 3(11):847-53. PubMed ID: 1467312 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of the arachidonic acid pathway prevents induction of IL-8 mRNA by phorbol ester and changes the release of IL-8 from HL 60 cells: differential inhibition of induced expression of IL-8, TNF-alpha, IL-1 alpha, and IL-1 beta. Meier RW; Niklaus G; Dewald B; Fey MF; Tobler A J Cell Physiol; 1995 Oct; 165(1):62-70. PubMed ID: 7559807 [TBL] [Abstract][Full Text] [Related]
36. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. Sanceau J; Wijdenes J; Revel M; Wietzerbin J J Immunol; 1991 Oct; 147(8):2630-7. PubMed ID: 1918983 [TBL] [Abstract][Full Text] [Related]
37. Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus. McGlynn E; Liebetanz J; Reutener S; Wood J; Lydon NB; Hofstetter H; Vanek M; Meyer T; Fabbro D J Cell Biochem; 1992 Jul; 49(3):239-50. PubMed ID: 1644861 [TBL] [Abstract][Full Text] [Related]
38. Factors influencing the effect of the soluble IL-6 receptor on IL-6 responses in HepG2 hepatocytes. Paysant J; Blanqué R; Vasse M; Soria C; Soria J; Gardner CR Cytokine; 2000 Jun; 12(6):774-9. PubMed ID: 10843763 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Mimata Y; Kamataki A; Oikawa S; Murakami K; Uzuki M; Shimamura T; Sawai T Int J Rheum Dis; 2012 Feb; 15(1):36-44. PubMed ID: 22324945 [TBL] [Abstract][Full Text] [Related]
40. Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells. Thabard W; Collette M; Bataille R; Amiot M Biochem J; 2001 Aug; 358(Pt 1):193-200. PubMed ID: 11485567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]